Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
- 1 June 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9220) , 2015-2020
- https://doi.org/10.1016/s0140-6736(00)02347-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast CancerNew England Journal of Medicine, 1999
- Prophylactic Mastectomy — The Price of FearNew England Journal of Medicine, 1999
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Should prophylactic surgery be used in women with a high risk of breast cancer?European Journal Of Cancer, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Predictors of and Satisfaction with Bilateral Prophylactic MastectomyPreventive Medicine, 1995
- Interest in genetic testing among first‐degree relatives of breast cancer patientsAmerican Journal of Medical Genetics, 1995
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994